OR WAIT null SECS
December 01, 2021
CordenPharma will build a clinical trial development facility for manufacture of oral solid dosage drug products at its Plankstadt facility near Heidelberg, Germany.
November 29, 2021
Novozymes and Novo Nordisk Pharmatech are teaming up to develop best-in-class technical enzymes to support biopharmaceutical production processes.
Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp. have partnered to advance GreenLight’s mRNA COVID-19 vaccine candidate.
Donaldson Company's acquisition of Solaris Biotechnology is intended to expand their footprint in the life sciences market.
Flywheel's platform will aid Roche and Genentech in the aggregation and management of medical imaging data.
November 26, 2021
ACG plans to open a capsule manufacturing plant and R&D center in Aurangabad, India.
Benchling raised $100 million to expand in Europe and further develop it's cloud-based R&D platform.
November 25, 2021
AstraZeneca has unveiled its new facility, The Discovery Centre, which will be used to support the company's focus on precision and specialized medicines, and to foster industry collaboration.
Eppendorf has donated €20,000 (US$22,400) to the European Molecular Biology Laboratory (EMBL) in support of the “Advancement of Women in Science” project.
The EC has granted marketing authorization for Gilead’s Trodelvy for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer.